Detalhe da pesquisa
1.
Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure.
Clin Infect Dis
; 77(10): 1423-1431, 2023 11 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37340869
2.
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.
Antimicrob Agents Chemother
; 67(4): e0005323, 2023 04 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36995219
3.
Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.
N Engl J Med
; 382(12): 1124-1135, 2020 03 19.
Artigo
Inglês
| MEDLINE | ID: mdl-32130806
4.
HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention.
J Infect Dis
; 226(12): 2170-2180, 2022 12 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36240386
5.
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084.
J Infect Dis
; 225(10): 1741-1749, 2022 05 16.
Artigo
Inglês
| MEDLINE | ID: mdl-35301540
6.
Impact of Integrase Sequences from HIV-1 Subtypes A6/A1 on the In Vitro Potency of Cabotegravir or Rilpivirine.
Antimicrob Agents Chemother
; 66(3): e0170221, 2022 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34978890
7.
Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.
J Infect Dis
; 224(9): 1581-1592, 2021 11 16.
Artigo
Inglês
| MEDLINE | ID: mdl-33740057
8.
Safety and efficacy of GSK2248761, a next-generation nonnucleoside reverse transcriptase inhibitor, in treatment-naive HIV-1-infected subjects.
Antimicrob Agents Chemother
; 56(5): 2570-5, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22314532
9.
Long-Term Efficacy, Safety, and Durability of Cabotegravir and Rilpivirine as 2-Drug Oral Maintenance Therapy After 6 Years of Study.
Open Forum Infect Dis
; 9(4): ofac067, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35350172
10.
Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study.
Lancet HIV
; 8(11): e668-e678, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34656207
11.
Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study.
Lancet HIV
; 8(4): e185-e196, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33794181
12.
Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study.
Open Forum Infect Dis
; 8(9): ofab439, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34557563
13.
A pilot study of abacavir/lamivudine and raltegravir in antiretroviral-naïve HIV-1-infected patients: 48-week results of the SHIELD trial.
HIV Clin Trials
; 11(5): 260-9, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-21126956
14.
Dissolved phosphate concentrations in Iowa shallow groundwater.
J Environ Qual
; 49(4): 909-920, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33016492
15.
Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials.
J Acquir Immune Defic Syndr
; 85(4): 498-506, 2020 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33136751
16.
Prevalence of pretreatment and acquired HIV-1 mutations associated with resistance to lamivudine or rilpivirine: a systematic review.
Antivir Ther
; 24(6): 393-404, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31503008
17.
Once-daily abacavir/lamivudine and ritonavir-boosted atazanavir for the treatment of HIV-1 infection in antiretroviral-naïve patients: a 48-week pilot study.
HIV Clin Trials
; 9(3): 152-63, 2008.
Artigo
Inglês
| MEDLINE | ID: mdl-18547902
18.
Short Communication: Dolutegravir-Based Regimens Are Active in Integrase Strand Transfer Inhibitor-Naive Patients with Nucleoside Reverse Transcriptase Inhibitor Resistance.
AIDS Res Hum Retroviruses
; 34(4): 343-346, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29444582
19.
Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection.
J Acquir Immune Defic Syndr
; 78(2): 125-135, 2018 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29474268
20.
Simplified maintenance therapy with abacavir/lamivudine and atazanavir after discontinuation of ritonavir.
HIV Clin Trials
; 11(3): 170-3, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-20736153